A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores

ALERT: A cyber incident at Optum/Change Healthcare may delay Luminis Health bill processing. Watch for fraud and verify any concerning messages with your provider's office. We are working to minimize disruptions.

Primary Author not in Drupal

Fujii T

Title of the Project

A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores

Service Line in Drupal

Oncology

Format of the Project

Journal Article

Affiliated Specialties not in Drupal

Medical Oncology

Name of Publication

Breast Cancer Res Treat. 2021 Jun 15. doi: . Online ahead of print.

Date of Publication

Tue, 06/15/2021 - 12:00